Secondly, expression of LRP6 is downregulated in AD brain [49], and deficiency in LRP6-mediated Wnt/β-catenin signaling contributes to synaptic dysfunction and amyloid pathology in AD [49]. This evidence concerns the gene LRP6 and Alzheimer disease.